Kevin Jung
Vice President, Head of Global Business Division G2GBIO Inc.
Seminars
Thursday 10th December 2026
InnoLAMP™ Microparticle Technology for Sustained CNS Delivery: A Once-Monthly Donepezil Formulation
11:30 am
- Highlighting how long-acting microsphere technology could be applied for CNS indications, with reference to G2GBIO’s pipeline as an example
- Explaining the drug-release mechanism of microspheres in the CNS
- Demonstrating PK profile of monthly injectable Donepezil in animals and humans
